Shares of Predictive Technology Group Inc. (OTCMKTS:PRED) are among the top penny stock gainers over the past month. The PRED stock has almost doubled on increase volume since April 16th. In fact the stock has jumped 52% this week alone amid multiple press releases. The biggest news was the company’s submission of its application to list its common stock on NASDAQ.
On May 07, Predictive Technology Group Inc. (OTCMKTS: PRED) has announced that its 100% owned subsidiary Predictive laboratories has enrolled 200 subjects in the Institutional Review Boards approved study for chronic joint and spine pain disease.
In other developments, yesterday the company announced the appointment a new Board of Directors Committee Chair and submitted an application to list its common stock on NASDAQ.
For more Small Cap Exclusive info and updates, subscribe here:
The goal of the IRB approved study is to carry out genetic research in diagnosis, prevention, and treatment of causative factors of chronic pain. The company has indicated that they have enrolled 200 volunteer participants who have already given their DNA samples to the Predictive Laboratories’ Biorepository as well as the provision of medical reports from their healthcare providers.
Bradley Robinson the CEO of Predictive Technology Group stated that in every five American adults at least one suffers from chronic pain and opioid use has led to increased addiction and overdose as patients try to find relief. He stated that there has been a positive response from patients who have enrolled in the study in search of a better solution to the pain. This will be a great milestone for predictive technology which will use its analytic capabilities to add genetic data to its robust pipeline to help in therapeutic treatments for the disease.
Appointment of Committee Chairs
In a quarterly meeting held on May 8, 2019, Predictive Technology completed its board committee appointments. John Sorrentinothe Chairman announced that Jay Moyes will be chairing the Audit and Compliance Committee while Ron Barhorst will chair the Compensation Committee. Sorrentino will be chairing the Nominating Committee.
Sorrentino said that the board has made great progress in setting predictive technology’s future by filling the important roles and welcoming of new board members.
Submission of NASDAQ listing application
Predictive Technology management has submitted an application to list its common shares on the NASDAQ Exchange. This is subject to NASDAQ approval and fulfillment of the necessary listing standards.